From Dr. Jekyll to Mr. Hyde of cancer immunotherapy – Medical Xpress – Medical Xpress
|
From Dr. Jekyll to Mr. Hyde of cancer immunotherapy – Medical Xpress
Medical Xpress Novel immunotherapies can strengthen the body’s own defenses against cancer cells. Treatment of patients with advanced disease can promote partial and … |
PharmaTimes |
GSK, Plasticell Partner to Produce Hematopoietic Cells from iPSCs
Genetic Engineering & Biotechnology News Plasticell will use the bead-based CombiCult platform to produce hematopoietic cells from induced pluripotent stem cells (iPSCs) by optimizing the directed differentiation of the iPSCs to specific blood cell lineages for use by GSK in therapeutic … GSK taps Plasticell’s iPSC differentiation techBioPharma-Reporter.com GSK, Plasticell sign deal to produce haematopoietic cellsPharmaTimes |
|
Agilent launches new SureGuide CRISPR activation and interference libraries
Zenopa Agilent Technologies has announced the launch of new SureGuide pooled libraries for CRISPR activation and interference. The latest additions to the company’s range of pooled SureGuide CRISPR libraries for functional genomics will be created using … |